基于245例原发性肝癌病死病例分析试论原发性肝癌扶正从气血论治  

Analysis on treating liver cancer from regulating qi and blood based on 245 cases of liver cancer deaths

作　　者：高峰[1] 韩颖盈[1] 杨金祖[1] 王强[1] 杨金坤[1] 

机构地区：[1]上海中医药大学附属龙华医院肿瘤一科,上海200032

出　　处：《中华中医药杂志》2017年第1期117-120,共4页China Journal of Traditional Chinese Medicine and Pharmacy

基　　金：国家中医药管理局中医临床指南应用评价项目[No.ZYYBZ-2013(PJ26)]~~

摘　　要：目的:探索中医药治疗原发性肝癌(以下简称肝癌)的有效方法。方法:总结近23年来245例肝癌病死病例,分析其严重并发症及病死率构成比变化,总结中医药在治疗肝癌中的有效性。结果:全部245例肝癌患者中位生存时间为5个月;2003年之前102例中位生存时间为4个月,2003年以来143例中位生存时间为5个月;接受过介入等局部治疗的95例患者中位生存时间为7个月。结论:肝癌的临床疗效逐步提高,以益气宁血为主的扶正治疗可能是肝癌扶正治疗的根本所在。Objective：To Explore the effective methods of treating primary liver cancer（PLC） with traditional Chinese medicine（TCM）.Methods：To summarize the 245 cases of liver cancer deaths in recent 23 years,analyze the serious complication and mortality ratio,and summarize the effectiveness of TCM in the treatment of liver cancer.Results：The median survival time of all 245 patients with PLC was 5 months.Before 2003,the median survival time of 102 patients was 4 months.Since 2003,the median survival time of 143 patients was 5 months.The median survival time of the 95 patients who underwent local therapy such as interventional therapy was 7 months.Conclusion：Clinical efficacy of liver cancer gradually increases,and treatment of strengthening body resistance give priority to tonifying qi and pacifying blood may be the root of liver cancer treatment.

关 键 词：原发性肝癌 构成比 中医药治疗 扶正 益气宁血 

分 类 号：R273[医药卫生—中西医结合]